VolitionRX Ltd. VNRX 深 滬
等待開盤 09-06 09:30:00 美东时间
0.602
-0.033
-5.18%
華盛通- 最 高0.644
- 今 開0.644
- 成交量 36.36万股
- 最 低 0.5713
- 昨 收 0.6349
- 總市值 6260.80万
- 52周最高 0.94
- 市盈率 靜 --
- 換手率 0.35%
- 52周最低 0.3951
- 委 比 -33.33%
- 總股本 1.04亿
- 歷史最高 9.28
- 量 比 2.04
- 振 幅 11.45%
- 歷史最低 0.3951
- 每 手 1
- 風險率 0.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多VolitionRx shares are trading higher after the company reported a Q2 revenue beat.
VolitionRx shares are trading higher after the company reported a Q2 revenue be...
08-16 01:43
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.
08-15 22:33
VolitionRX Q2 EPS $(0.06) Misses $(0.05) Estimate, Sales $406.688K Beat $379.000K Estimate
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 25 percent increase over losses of $(0.08) per share from the same
08-15 05:30
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Insights into VolitionRX's Upcoming Earnings
VolitionRX (AMEX:VNRX) will release its quarterly earnings report on Thursday, ...
08-14 01:03
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation
HENDERSON, Nev., July 16, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today provides an update on the significant comme...
07-16 20:00
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.
07-09 19:12
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 171.6% to $27....
07-07 20:07
美股机会日报丨美国5月CPI全线低于预期！马斯克主动认错，特斯拉盘前涨超3%
美国5月CPI数据全线低于预期！三大期指直线拉升；戏剧性转折！马斯克后悔发帖怒喷特朗普，特斯拉盘前涨超3%；量子计算新时代开启？黄仁勋谈拐点到来，概念股涨势如虹>>
06-11 20:36
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
